Australia, Oct. 8 -- AOP Orphan Pharmaceuticals Gmbh, owns the trademark (2526064) for 'RAPIBLYK' till Feb. 27, 2035.
Status: registered:
Registered/protected
Class: 5 [Pharmaceutical and veterinary preparations, namely, cardiovascular treatment preparations acting on the cardiovascular system and CNS; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for the treatment of tachyarrhythmias, tachycardias and atrial fibrillation; pharmaceutical preparations for the emergency treatment of tachyarrhythmias, tachycardias and atrial fibrillation]
Type of Mark: Word
Date of Acceptance: March 6
Registration Advertised: Oct. 7
For further details contact Davies Collison Cave Pty. Ltd. .
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2526064.
Disclaimer: Curated by HT Syndication.
